Prince Street Capital Management LLC Hutchmed (China) LTD Transaction History

Prince Street Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$17.84 - $22.69 $1.45 Million - $1.85 Million	-81,400 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$28.87 - $41.13 $580,287 - $826,713	20,100 Added 32.79%	81,400 $2.41 Million
Q4 2017 Feb 14, 2018	SELL	$27.41 - $39.42 $219,280 - $315,360	-8,000 Reduced 11.54%	61,300 $2.42 Million
Q3 2017 Nov 14, 2017	BUY	$22.15 - $27.5 $1.53 Million - $1.91 Million	69,300	69,300 $1.89 Million

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Prince Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prince Street Capital Management LLC with notifications on news.